Companies
CSPC Innovation Pharma
a subsidiary of CSPC Pharmaceutical Group, manufactures caffeine, theobromine and other methylxanthine APIs for global pharmaceutical supply, with DMF registrations supporting exports to regulated markets.
- Country
- China
- Ticker
- HKEX:1093
Commercial
Caffeine & theobromine API; DMF-registered; HKEX: 1093; founded 1992
cn
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | 1991 | en.xnwpharma.net |
| Headcount | 2,369 employees | marketscreener.com |
| Revenue | 3,240,242,226.11 Yuan | doc.irasia.com |
| Revenue | 3,240,242,226.11 Yuan (2026-06-30) | doc.irasia.com |
| Certification | GMP, ISO system, BRC, KOSHER | en.xnwpharma.net |
| Certification | CEP | apibureau.com |
| Regulatory approval | US-DMF, EU-GMP, PMDA (Japan) | chemxpert.com |
| Regulatory approval | CDE, DMF, CEP | apibureau.com |
| Production site | two manufacturing campuses (north and south) in Shijiazhuang, China, and a factory area in Taizhou | en.xnwpharma.net |
Independent sources: apibureau.com · chemxpert.com · doc.irasia.com · en.xnwpharma.net · marketscreener.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic theobromine | specialty-fine-chem | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.